Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - constitutive androstane receptor (CAR) - Bcr-Abl
清除全部
- B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂
- B5846 Radotinib(IY-5511)中文名: 雷多替尼Target: PDGFR|Bcr-AblSummary: Bcr-Abl酪氨酸激酶抑制剂
- B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体(CAR)激动剂
- B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂
- B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂
- B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂
- B1299 1-NM-PP1Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-FynSummary: Pp60c-src抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂